CBNT News Update & More

C-Bond Systems, Inc. CBNT – News Update

We were covering CBNT all last month, wherein we witnessed a run of over 130% as the stock traded from a low of .05-.1162 in a span of just a couple of weeks. We wanted to kick off this week by passing along the company’s fresh PR to any of our readers who may still be following its story.

CBNT is in the running for the 2019 Fleet Europe Innovation Award with its NanoShield™ technology, and for what it’s worth, they have our vote.

HOUSTON, Nov. 04, 2019 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology company that improves and strengthens glass, announced today that the C-Bond NanoShield™ final presentation for the 2019 Fleet Europe Innovation Award will be held on November 6, 2019, at the Fleet Europe Summit in Estoril, Portugal. The winner will be announced on November 7th.  To vote for C-Bond NanoShield please visit the Fleet Europe Innovation Award website at https://votes.fleeteurope.com/innovation.html#.XbwuWT-oskl. (>>View Full PR)



Options Recap

We offered up a few fresh ideas for Friday’s session. These were the big winners of the bunch:

Alibaba Group Holding Ltd. BABA Weekly $175-180 Calls
$175 Calls
– Range: 3.00-7.05  Max Gain: 135%
$180 Calls – Range: .44-2.45  Max Gain: 457%

US Steel Corp. X Weekly $12 Calls 

$12 Calls – Range: .31-1.75  Max Gain: 465%
_____

Fresh Ideas:
UAA Weekly $19.50-18 Puts
RACE Weekly $167.50-172.50 Calls 


Extended Watchlist:
AWSM, USM, ASNA, PIRS, OCGN, ACOR, HTBX

Blue Horseshoe Stocks: Options Review

Nike Inc. NKE 

The first of two fresh options ideas submitted in our report in yesterday’s premarket, our NKE targets provided us with some good opportunities early on in the session.

It was the NKE Weekly $89-91 Calls, and despite low volume in the $90.50’s, the rest of those targets worked out just fine. Here are the total possible intraday gains that were on the table.

$89 Calls – Range: 1.69-2.69 – Max Gain: 59%
$89.50 Puts – Range: 1.32-2.06 – Max Gain: 56%
$90 Calls – Range: .99-1.77 – Max Gain: 79%
$91 Calls – Range: .55-1.10 – Max Gain: 100%


SPDR S&P500 (ETF) SPY

By now, our regular readers should know that the SPY is often our go-to target for on-the-fly options ideas. It’s a market analog that has rarely failed us in the past.

Yesterday’s idea of the SPY Weekly $296-297 Calls was no exception to this. Here are the single-session gins that were possible with these ideas.

$296 Calls – Range: 1.06-2.70 – Max Gain: 155%
$296.50 Puts – Range: .85-2.32 – Max Gain: 173%
$297 Calls – Range: .67-1.95 – Max Gain: 146%

The SPY is gapping up again this morning. We’d expect to see these gains extended, and will expand our track list to include the $297.50 and $298 Calls as well.


Fresh Options Ideas:
KBH Weekly 10/18 $32-33 Calls 


Extended Watchlist:
PIRS, AREX, EYRN, DHT, STNG, GMO, VBIV

Blue Horseshoe Stocks: OSTK Update & More

Overstock.com, Inc. OSTK

On Friday, we identified a  pair of options targets for OSTK, the 10/04 $15.50 & 16 Calls. Despite falling to the low side toward the end of the day, there were some early opportunities for our designated contracts.

The $15.50 Calls traded up from 1.50-1.90 for a notable 27% intraday move, while the $16 Calls traded in a range from 1.40-1.96 (+40%).

With the late session dip, OSTK fell considerably, but we view this as no less than a buy-in opportunity on these very same contracts. We like the chances of seeing a quick rebound, and the potential for further gains out of these plays over the course of the next trading week or two.


Fresh Options Ideas:
ROKU 11/01 $115-118 Calls


Extended Watchlist:
MDR, AVDL, KNDI, OGEN, DRD, NTEC, CANF, PIRS, INPX

Blue Horseshoe Stocks: PIRS Review & More

Pieris Pharmaceuticals Inc. PIRS – Review

Of all the types of plays we search for, bottom watch plays can require the most amount of patience as compared to other quick-strike ideas that we formulate. We highlighted PIRS as such back in mid-February, and over the past quarter, the stock has produced some very favorable results in two distinct runs.

When we initially signaled our interest in this stock, or shortly thereafter, it was trading for as little as 2.83 and over the course of the next two months, it gradually made its way to 4.00 (+41%). After a pullback down near its original level at 2.81 halfway through last month, the stock has begun to run once again. This time it has reached all new highs, with the stock changing hands for as much as 4.68/share on Friday. That second push allowed us to see an overall increase of 67%

We wouldn’t be at all surprised to have to come back to PIRS once again in the near future. In addition to the company’s joint clinical venture with pharma super giant AstraZeneca, the stock itself has recently received analyst upgrades that could just be the beginning of PIRS’s next leg-up.


Xalles Holdings, Inc. XALL

We are also looking at the incredible momentum recently built up by XALL, which has been assisted by the resurgence of Bitcoin here in 2019, which began in January in the mid-$3000 range, and has persisted to the present time to the current highs near $8700.

The company also recently decreased its public float by around 50%, making it that much easier for the stock to move. We’ll be interested to continue to monitor its progress, especially if the latest Bitcoin boom continues to persist as it has in recent months.


Extended Watchlist:
DRRX, CBLK, BLNK, CTRV, MOSY, SNSS, NVCN, ATVI, LAHO(>>News Alert)

Blue Horseshoe Stocks: Form-4 Alert & More

Snap, Inc. SNAP – Update

Even as the markets got crushed yet again yesterday despite it appearing as if the worst of the downturn was over, SNAP still managed to produce gains in our updated options trading targets.

It was in our premarket report yesterday that we were updating readers on the previous idea we had with the SNAP $16-17.50 Calls, which made moves ranging from 335-700% the day prior.

The stock had risen by such a large margin that we rolled up our potential strike prices to the $21-22.50 levels, and we got very nice activity out of half of those calls to keep our success with the SNAP options chain rolling.

The $21 Calls ran from .04-.32, for a fantastic 700% rip, while the 21.50’s made a 400% from .03-.15.
________

Fresh Options Idea:

Provided the SPY holds above 259.50 we’ll be interested in the SPY Weekly $260.50-262 Calls*

*Please do not attempt to trade weekly options on a Friday unless you are an expert level trader with disposable funds.



LendingClub Corp. LC

With turmoil in the markets persisting, this is a time when we want to stick to our technicals, and look for stocks that are currently boasting the type of chart setups we routinely scan for, and LC currently matches the profile.

The stock has come down to double-bottom with a gap to fill to the upside, as you can see on the included snapshot. We feel that over the next few weeks, LC could be in line for a solid recovery.

In addition to the stock itself, we’re going to radar a pair of options contracts to track over a more extended period of time, with the LC 03/16 $3.50 & $4 Calls.


Seattle Genetics, Inc. SGEN – Form-4 Alert

While we’re on the subject of bottom-plays, we’ve got SGEN hitting our scanner this morning. We’ll include a chart snapshot of this one as well, so you can see what we find so attractive about it. We’ve got a triple-bottom formation happening with the stock coming down to he $50-range, and a recent track record of the type of volatility we’re after.

To sweeten the pot, a major Form-4 buy came in the last week at $52, to the tune of $200M (View EDGAR Filing) in addition to a multi-program immuno-oncology collaboration with Pieris Pharmaceuticals announced this morning.

We’re going to track the SGEN 03-16 $50 Calls in the days and weeks ahead.


Extended Watchlist:
PIRS, AVIN, CTRL, CFMS, CNET, INPX